Scilex Holding (SCLX) Inventory Average (2023 - 2026)

Scilex Holding (SCLX) posted quarterly Inventory Average of $4.7 million for Q1 2026, up 70.93% year-over-year from $2.7 million in Q1 2025, and up 58.76% on a QoQ basis from $2.9 million in Q4 2025.

Scilex Holding (SCLX) Inventory Average (2023 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Inventory Average for 4 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Inventory Average rose 70.93% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (up 70.93% YoY), while the FY2025 annual figure was $3.6 million, up 8.65% from the prior year.
  • Inventory Average came in at $4.7 million for Q1 2026 at Scilex Holding, up from $2.9 million in the prior quarter.
  • The five-year high for Inventory Average was $4.7 million in Q1 2026, with the low at $1.8 million in Q3 2025.
  • Average Inventory Average over 4 years is $3.0 million, with a median of $2.8 million recorded in 2025.
  • The largest YoY upside for Inventory Average was 110.79% in 2024 against a maximum downside of 40.66% in 2024.
  • Year by year, Inventory Average stood at $4.1 million in 2023, then tumbled by 40.66% to $2.4 million in 2024, then increased by 21.3% to $2.9 million in 2025, then surged by 58.76% to $4.7 million in 2026.
  • According to Business Quant data, Inventory Average over the past three periods registered $4.7 million, $2.9 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 14.14 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 14.39 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 5.00 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 6.56 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 6.57 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 6.21 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 1.84 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 10.66 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 4.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.66 Mn
Dec 31, 2025 2.94 Mn
Sep 30, 2025 1.80 Mn
Jun 30, 2025 2.77 Mn
Mar 31, 2025 2.73 Mn
Dec 31, 2024 2.42 Mn
Sep 30, 2024 2.74 Mn
Jun 30, 2024 3.28 Mn
Mar 31, 2024 3.85 Mn
Dec 31, 2023 4.08 Mn
Sep 30, 2023 3.53 Mn
Jun 30, 2023 2.69 Mn
Mar 31, 2023 1.83 Mn